Company news
Yabao Pharmaceutical Group Co. Ltd. news in 2025
Yabao Pharmaceutical Group Co. Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Progress in the Sale of Subsidiary Equity and Completion of Industrial and Commercial Registration Change
December 22, 2025
Announcement on Profit Distribution Plan for Q3 2025
December 19, 2025
Announcement on Obtaining Notice of Approval for Drug Clinical Trials of GLX002
December 17, 2025
Announcement on the Change of Signatory Certified Public Accountant and Quality Control Reviewer for the Audit Institution
December 12, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 21, 2025
Announcement on Implementation Result of Shares Repurchase and Share Changes
November 17, 2025
Announcement on Obtaining the Registration Certificate for Formula Foods for Special Medical Purposes
November 12, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
November 3, 2025
Announcement on Progress in Repurchased Company Shares Reaching 1% and Repurchase
October 30, 2025
Report for Q3 2025
October 24, 2025
Announcement on Early Repurchase of Shares in Stock Pledge Repurchase Transactions by the Controlling Shareholder
September 29, 2025
Announcement on Holding Shareholders Engaging in Stock Pledge Repurchase Transactions
September 26, 2025
Announcement on Obtaining Notice of Approval for Drug Clinical Trials of ZY-A002
September 23, 2025
Announcement on Termination of Clinical Trials for Research Projects and the Provision of Impairment Provisions
September 22, 2025
Announcement on Obtaining Notice of Approval for Drug Clinical Trials of SY-005 with New Indications
August 25, 2025
2025 Semi-annual Report
August 15, 2025
Announcement on Signing the Technology Transfer Agreement for the New Traditional Chinese Medicine Project
August 5, 2025
Announcement on Initially Repurchasing the Company's Shares through Call Auction
July 10, 2025
Announcement on Transfer of Partnership Shares to Wholly-Owned Subsidiaries and Withdrawal from Partnership
July 4, 2025
Announcement on Obtaining Commitment Letter for Share Repurchase Loans from Financial Institutions
June 23, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 29, 2025
Announcement on Implementation of Dividend Distribution for 2024
May 23, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 16, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Shanxi Jurisdiction
May 14, 2025
Announcement on Shareholding of Top 10 Shareholders Concerning Shares Repurchase
May 12, 2025
2024 Annual Report
April 25, 2025
Announcement on Release of Pledge of Some Shares of Controlling Shareholder
April 18, 2025
Announcement on Implementation Results of Share Repurchase and Share Changes
March 3, 2025
Announcement on ZY-A001 Obtaining Notice of Approval for Drug Clinical Trials
February 14, 2025
Announcement on the Repurchased Company Shares Reaching 1% and Repurchase Progress
February 5, 2025
Announcement on the Termination of the Technology Transfer Agreement for the Traditional Chinese Medicine New Drug Project
January 17, 2025